County
Adams, Benton, Franklin, Yakima Counties
Drugs and doses53
A–C Acetaminophen, Adenosine, Albuterol, Albuterol-Ipratropium, Amiodarone, Ampicillin, Aspirin, Atropine, Azithromycin, Calcium Chloride, Calcium Gluconate, Ciprofloxacin12
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 20 mg/kg | PO/PR | not captured | standing | pages 74, 170 |
| Mild to moderate pain | adult | 650–1000 mg | PO | not captured | standing | pages 52, 118, 170 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | pages 52, 118, 170 |
| Seizure | peds | 20 mg/kg | PR | not captured | standing | pages 74, 170 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 6 mg | IV | not captured | standing | pages 45, 170 |
| Other | adult | 6 mg | IV | not captured | standing | pages 45, 142 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 45, 170 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 45, 142 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 54, 79, 81, 82, 170, 177 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 54, 79, 81, 82, 170, 177 |
| Other | adult | 0.5 mL | NEB | not captured | standing | page 79 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 170 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 54 |
| Other | adult | 5–10 mg | NEB | not captured | standing | page 49 |
| Other | peds | 0.5 mL | NEB | not captured | standing | page 82 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 170 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 82 |
Albuterol-Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 3 mL | NEB | not captured | standing | pages 79, 81, 82 |
| Asthma / bronchospasm | peds | 3 mL | NEB | not captured | standing | pages 79, 81, 82 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | pages 43, 171 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | pages 43, 171 |
| Other | adult | 150 mg | IV | not captured | standing | pages 45, 171 |
| Other | adult | 150 mg | not captured | not captured | standing | page 45 |
| Other | adult | 150 mg | not captured | not captured | standing | page 195 |
| Other | adult | 300 mg | not captured | not captured | standing | page 43 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 171 |
| Other | peds | 5 mg/kg | not captured | not captured | standing | page 45 |
| Other | peds | 5 mg | IV/IO | not captured | standing | page 171 |
| Other | peds | 5 mg/kg | not captured | not captured | standing | page 43 |
Ampicillin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 500 mg | IV | not captured | standing | page 154 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 324 mg | PO | not captured | standing | pages 39, 171 |
| Other | adult | 324 mg | not captured | not captured | standing | page 39 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV | not captured | standing | pages 37, 172 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | pages 37, 172 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV | not captured | standing | page 172 |
| Other | adult | 1 mg | IV | not captured | standing | page 37 |
Azithromycin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 500 mg | IV | not captured | standing | page 155 |
| Other | adult | 500 mg | IV | not captured | standing | page 155 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV | not captured | standing | page 73 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–2 g | IV | not captured | standing | pages 49, 73, 173 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–2 g | IV | not captured | standing | pages 49, 73, 173 |
| Other | adult | 1–2 g | IV | not captured | standing | pages 49, 173 |
| Other | adult | 1–2 g | IV | not captured | standing | page 173 |
Ciprofloxacin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 400 mg | IV | not captured | standing | page 155 |
| Other | adult | 400 mg | IV | not captured | standing | page 155 |
| Other | adult | 400 mg | IV | not captured | standing | page 155 |
| Other | adult | 400 mg | IV | not captured | standing | page 155 |
D–F Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Droperidol, Epinephrine, Etomidate, Fentanyl9
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | pages 64, 65, 72, 74, 75, 76, 77, 175 |
| Hypoglycemia | peds | 0.5–1 g/kg | IV/IO | not captured | standing | pages 64, 65, 72, 74, 75, 76, 77, 175 |
| Hypoglycemia | peds | 0.5–1 g/kg | IV | not captured | standing | pages 64, 65 |
| Other | adult | 25 g | IV | not captured | standing | page 74 |
| Other | adult | 25 g | IO | not captured | standing | page 175 |
| Other | adult | 25 g | IV | not captured | standing | page 76 |
| Other | adult | 25 g | IV | not captured | standing | page 72 |
| Other | peds | 0.5–1 g/kg | IV | not captured | standing | page 175 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–5 mg | IV/IM | not captured | standing | page 176 |
| Agitation | adult | 2–5 mg | IV/IM | not captured | standing | page 176 |
| Other | adult | 2–10 mg | IV/IM | not captured | standing | page 176 |
| Other | peds | 0.1–0.3 mg/kg | IV/IM | not captured | standing | page 176 |
| Procedural sedation | adult | 2–10 mg | IV/IM | not captured | standing | page 176 |
| Procedural sedation | peds | 0.1–0.3 mg/kg | IV/IM | not captured | standing | page 176 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.25 mg/kg | IV | not captured | standing | pages 45, 176 |
| Other | adult | 0.25 mg/kg | IV | not captured | standing | page 45 |
| Other | adult | 0.25 mg/kg | IV | not captured | standing | page 176 |
| Other | adult | 5–15 mg | IV | not captured | standing | page 195 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 177 |
| Allergic reaction | adult | 25–50 mg | PO | not captured | standing | pages 54, 177 |
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | pages 54, 177 |
| Allergic reaction | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 177 |
| Allergic reaction | peds | 1–2 mg/kg | PO | not captured | standing | pages 54, 177 |
| Allergic reaction | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | pages 54, 177 |
| Other | adult | 25–50 mg | IV/IM | not captured | standing | page 177 |
| Other | adult | 25–50 mg | IV/IM/PO | not captured | standing | page 177 |
| Other | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 54 |
| Other | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 54 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–10 mcg/kg | IV | not captured | standing | pages 177, 195, 196 |
| Other | adult | 15 mcg/kg | IV | not captured | standing | page 196 |
| Other | adult | 2–10 mcg/kg | IV | not captured | standing | page 177 |
| Other | adult | 2 mcg/kg | IV | not captured | standing | page 196 |
| Other | adult | 2–5 mcg/kg | IV | not captured | standing | page 195 |
| Other | adult | 5 mcg/kg | IV | not captured | standing | page 196 |
| Other | adult | 5–10 mcg/kg | IV | not captured | standing | page 195 |
| Other | peds | 2–10 mcg/kg | IV | not captured | standing | page 177 |
| Other | peds | 2 mcg/kg | IV | not captured | standing | page 196 |
| Other | peds | 5 mcg/kg | IV | not captured | standing | page 196 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IV/IM | not captured | standing | pages 57, 182 |
| Other | adult | 5 mg | IV/IM | not captured | standing | pages 57, 182 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | pages 54, 55, 79, 80, 82, 178, 179 |
| Anaphylaxis | adult | 0.3–0.5 mg | IV/IO | not captured | standing | pages 55, 79, 178 |
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 54, 179 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 54, 55, 79, 80, 82, 178, 179 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 54, 179 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM/SQ | not captured | standing | pages 79, 80, 82, 178, 179 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IV | not captured | standing | pages 79, 178 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM/SQ | not captured | standing | pages 79, 80, 82, 178, 179 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | pages 37, 178, 179 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 37, 178, 179 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 43, 178, 179 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 178, 179 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 43, 178, 179 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 178, 179 |
| Other | adult | 0.3–0.5 mg | IM | not captured | standing | pages 54, 178 |
| Other | adult | 0.5 mg | not captured | not captured | standing | page 43 |
| Other | peds | 0.01 mg/kg | not captured | not captured | standing | page 43 |
| Other | peds | 0.15 mg | IM | not captured | standing | pages 54, 178 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3 mg/kg | IV | not captured | standing | page 108 |
| Other | peds | 0.3 mg/kg | IV | not captured | standing | page 108 |
| RSI induction | adult | 0.3 mg/kg | IV | not captured | standing | pages 108, 179 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mcg/kg | IV/IO | not captured | standing | pages 40, 180 |
| Other | adult | 1–3 mcg/kg | not captured | not captured | standing | page 50 |
| Other | adult | 100 mcg | IV/IO/IM | not captured | standing | pages 118, 180 |
| Other | adult | 1 mcg/kg | IV/IO | not captured | standing | page 180 |
| Other | adult | 2 mcg/kg | IN | not captured | standing | pages 118, 180 |
| Other | adult | 50 mcg | IV/IO/IM | not captured | standing | pages 118, 180 |
| Other | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | pages 118, 180 |
| Other | peds | 1 mcg/kg | IV/IO | not captured | standing | pages 40, 180 |
| Other | peds | 2 mcg/kg | IN | not captured | standing | pages 118, 180 |
| Mild to moderate pain | adult | 2 mcg/kg | IN | not captured | standing | pages 118, 180 |
| Post-intubation sedation | adult | 1–3 mcg/kg | IV | not captured | standing | pages 109, 180 |
G–L Glucagon, Heparin, Insulin, Ipratropium, Ketamine, Ketorolac, Levofloxacin, Lidocaine, Lorazepam9
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 64, 181, 182 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | pages 64, 181, 182 |
| Hypotension / shock | adult | 2 mg | IV | not captured | standing | pages 38, 50, 67, 72, 181, 182 |
| Other | adult | 1 mg | IM | not captured | standing | pages 64, 181 |
| Other | adult | 2 mg | IV | not captured | standing | pages 38, 181, 182 |
| Other | adult | 2 mg | IV | not captured | standing | pages 72, 182 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5000 unit | SQ | not captured | standing | page 160 |
| Other | adult | 5000–7000 unit | IV | not captured | standing | page 160 |
| Other | peds | 15–25 unit | IV | not captured | standing | page 160 |
| Other | peds | 50–100 unit/kg | IV | not captured | standing | page 160 |
Insulin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperglycemia / DKA | adult | 0.1 unit/kg | IV | not captured | standing | page 162 |
| Other | adult | 0.1 unit/kg | IV | not captured | standing | pages 161, 162 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mL | NEB | not captured | standing | page 79 |
| Other | adult | 2.5 mL | NEB | not captured | standing | pages 79, 81, 173, 177, 182 |
| Other | adult | 2.5 mL | NEB | not captured | standing | page 182 |
| Other | peds | 2.5 mL | NEB | not captured | standing | pages 79, 81, 173, 177, 182 |
| Other | peds | 2.5 mL | NEB | not captured | standing | page 182 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1–2 mg/kg | IV | not captured | standing | pages 57, 120, 183 |
| Agitation | adult | 250 mg | IM | not captured | standing | pages 57, 120, 183 |
| Agitation | peds | 1 mg/kg | IV | not captured | standing | pages 57, 120, 183 |
| Agitation | peds | 4 mg/kg | IM | not captured | standing | pages 57, 120, 183 |
| Other | adult | 1–2 mg/kg | IV | not captured | standing | pages 120, 183 |
| Other | peds | 1 mg/kg | IV | not captured | standing | pages 120, 183 |
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | pages 118, 183 |
| RSI induction | adult | 1–2 mg/kg | IV/IM | not captured | standing | pages 108, 183 |
| RSI induction | adult | 1–2 mg/kg | IM | not captured | standing | page 183 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | pages 118, 184 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | pages 118, 184 |
Levofloxacin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 500 mg | IV | not captured | standing | page 155 |
| Other | adult | 500 mg | IV | not captured | standing | page 155 |
| Other | adult | 500 mg | IV | not captured | standing | page 155 |
| Other | adult | 500 mg | IV | not captured | standing | page 155 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–0.75 mg/kg | IV | not captured | standing | page 45 |
| Other | adult | 0.5–0.75 mg/kg | IV/IO | not captured | standing | pages 45, 184 |
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 43 |
| Other | adult | 1 mg/kg | IV | not captured | standing | page 73 |
| Other | adult | 20–50 mg | IO | not captured | standing | pages 100, 101, 184 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 43 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 43, 171, 184 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 43, 171, 184 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 1–2 mg | IV/IM/IN | not captured | standing | pages 73, 185 |
| Agitation | adult | 1–2 mg | IV/IM/IN | not captured | standing | page 185 |
| Other | adult | 0.5–1 mg | IV | not captured | standing | page 185 |
| Other | adult | 1–2 mg | IV | not captured | standing | page 73 |
| Other | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 72 |
| Other | adult | 2–4 mg | IV/IM | not captured | standing | page 72 |
| Other | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | pages 75, 185 |
| Procedural sedation | adult | 1–2 mg | IV/IM/IN | not captured | standing | pages 122, 143, 185 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | pages 122, 143, 185 |
| Seizure | adult | 2–4 mg | IV/IM/IN | not captured | standing | page 75 |
| Seizure | adult | 2–4 mg | IV/IM/IN | not captured | standing | pages 70, 72, 75, 185 |
| Seizure | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | pages 70, 72, 75, 185 |
M–O Magnesium Sulfate, Methylprednisolone, Metoclopramide, Metronidazole, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose11
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 2–4 g | IV | not captured | standing | pages 70, 185, 186 |
| Other | adult | 2 g | IV | not captured | standing | pages 185, 186 |
| Other | adult | 2 g | IV | not captured | standing | pages 72, 185, 186 |
| Other | adult | 2 g | IV | not captured | standing | page 72 |
| Other | adult | 4 g | IV | not captured | standing | page 70 |
| Wide-complex tachycardia | adult | 2 g | IV | not captured | standing | pages 185, 186 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | pages 185, 186 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV | not captured | standing | pages 55, 191 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | pages 79, 80, 82, 191 |
| Asthma / bronchospasm | peds | 1–2 mg/kg | IV | not captured | standing | pages 79, 80, 82, 191 |
| COPD | adult | 125 mg | IV | not captured | standing | pages 81, 191 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5–10 mg | IV/IM | not captured | standing | pages 53, 186 |
| Other | adult | 5–10 mg | IV/IM | not captured | standing | page 53 |
| Other | adult | 5–10 mg | IV/IM | not captured | standing | page 186 |
| Other | adult | 5–10 mg | IV/IM | not captured | standing | page 68 |
Metronidazole
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15 mg/kg | IV | not captured | standing | page 156 |
| Other | adult | 15 mg/kg | not captured | not captured | standing | page 156 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–5 mg | IM/IN | not captured | standing | page 57 |
| Other | adult | 1–5 mg | IO/IM/IN | not captured | standing | page 72 |
| Other | adult | 1–5 mg | IM/IN | not captured | standing | page 72 |
| Other | adult | 1–5 mg | IV/IM | not captured | standing | page 120 |
| Other | adult | 1–5 mg | IV | not captured | standing | page 186 |
| Other | adult | 2.5–5 mg | IM | not captured | standing | page 108 |
| Post-intubation sedation | adult | 2.5–5 mg | IV | not captured | standing | pages 109, 186, 187 |
| Procedural sedation | adult | 1–5 mg | IV/IO | not captured | standing | pages 122, 186 |
| RSI induction | adult | 2.5–5 mg | IV/IM | not captured | standing | pages 108, 186, 187 |
| RSI induction | peds | 0.5–1 mg | IV/IM | not captured | standing | pages 108, 186, 187 |
| Seizure | peds | 0.2 mg/kg | IN | not captured | standing | page 75 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–10 mg | IM | not captured | standing | pages 118, 187 |
| Other | adult | 2–4 mg | IV | not captured | standing | pages 40, 187 |
| Other | adult | 4–20 mg | IV/IO/IM | not captured | standing | pages 118, 187 |
| Other | peds | 0.1–0.2 mg/kg | IM | not captured | standing | pages 118, 187 |
| Mild to moderate pain | adult | 2–10 mg | IV/IO | not captured | standing | pages 118, 187 |
| Mild to moderate pain | peds | 0.1–0.2 mg/kg | IV/IO | not captured | standing | pages 118, 187 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IN | not captured | standing | pages 71, 76, 188 |
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM | not captured | standing | pages 71, 72, 76, 188 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | pages 71, 76, 188 |
| Other | adult | 0.4–2 mg | IV/IO/IM/IN | not captured | standing | pages 71, 76, 188 |
| Other | adult | 0.4–2 mg | IV | not captured | standing | page 72 |
| Other | adult | 1 mg | IV/IO | not captured | standing | pages 188, 195 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 39, 40, 41, 188 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 41, 188 |
| CHF / pulmonary edema | adult | 2 inch | TOP | not captured | standing | pages 41, 189 |
| Other | adult | 0.4 mg | SL | not captured | standing | pages 39, 40, 188 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 2–4 mcg | IV/IO | not captured | standing | pages 38, 67, 78, 189 |
| Cardiogenic shock | peds | 0.1–2 mcg/kg | IV/IO | not captured | standing | pages 38, 67, 78, 189 |
| Other | adult | 2–4 mcg | IV | not captured | standing | page 72 |
| Other | adult | 2–4 mcg | IV | not captured | standing | page 73 |
| Other | adult | 4–10 mcg | IV | not captured | standing | page 43 |
| Sepsis | adult | 2–4 mcg | IV/IO | not captured | standing | pages 78, 189 |
| Sepsis | peds | 0.1–2 mcg/kg | IV/IO | not captured | standing | pages 78, 189 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4–8 mg | PO | not captured | standing | pages 52, 68, 189 |
| Nausea / vomiting | adult | 4–8 mg | IV/IO/IM | not captured | standing | pages 53, 68, 189 |
| Nausea / vomiting | adult | 4–8 mg | IV/IO/IM/PO | not captured | standing | pages 68, 189 |
| Nausea / vomiting | adult | 4–8 mg | IV/IO/IM | not captured | standing | pages 68, 189 |
| Nausea / vomiting | peds | 1 mg | IV/IO/IM/PO | not captured | standing | pages 68, 189 |
| Nausea / vomiting | peds | 1–4 mg | PO | not captured | standing | pages 52, 68, 189 |
| Nausea / vomiting | peds | 1–4 mg | IV/IO/IM | not captured | standing | pages 53, 68, 189 |
| Nausea / vomiting | peds | 2 mg | IV/IO/IM/PO | not captured | standing | pages 68, 189 |
| Nausea / vomiting | peds | 4 mg | IV/IO/IM | not captured | standing | pages 68, 189 |
| Other | adult | 4–8 mg | IV/IM | not captured | standing | page 53 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | pages 64, 98 |
P–R Potassium Chloride, Pralidoxime, Procainamide, Racemic Epinephrine, Rocuronium5
Potassium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mEq | IV | not captured | standing | page 169 |
| Other | adult | 10 mEq | IV | not captured | standing | pages 168, 169 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 1–2 g | IV | not captured | standing | page 173 |
| Organophosphate poisoning | peds | 20–40 mg/kg | IV | not captured | standing | page 173 |
| Other | adult | 1–2 g | not captured | not captured | standing | pages 172, 173 |
| Other | peds | 20–40 mg/kg | not captured | not captured | standing | pages 172, 173 |
Procainamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV/IO | not captured | standing | page 190 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 190 |
| Wide-complex tachycardia | adult | 20 mg | IV/IO | not captured | standing | page 190 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 190 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.25–0.5 mL | NEB | not captured | standing | pages 55, 80, 83, 190 |
| Other | peds | 0.25–0.5 mL | NEB | not captured | standing | pages 55, 80, 83, 190 |
| Other | peds | 0.25 mL | NEB | not captured | standing | pages 83, 190 |
| Respiratory distress | adult | 0.25–0.5 mL | NEB | not captured | standing | pages 55, 79, 80, 83, 190 |
| Respiratory distress | peds | 0.25–0.5 mL | NEB | not captured | standing | pages 55, 79, 80, 83, 190 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg/kg | IV/IO | not captured | standing | pages 109, 191 |
| Other | adult | 1–1.5 mg/kg | IV | not captured | standing | pages 109, 191 |
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 109, 191 |
S–Z Sodium Bicarbonate, Succinylcholine, Thiamine, Tranexamic Acid, Vancomycin, Vasopressin, Ziprasidone7
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mEq/kg | IV | not captured | standing | pages 44, 191 |
| Other | adult | 1 mEq/kg | IV | not captured | standing | page 73 |
| Other | adult | 1 mEq/kg | IV | not captured | standing | page 191 |
| Other | peds | 1 mEq/kg | IV | not captured | standing | pages 44, 191 |
| Other | peds | 1 mEq/kg | IV | not captured | standing | page 191 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | pages 72, 191 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mg/kg | IV/IO | not captured | standing | page 192 |
| Other | adult | 1–2 mg/kg | IV | not captured | standing | pages 108, 192 |
| Other | adult | 2 mg/kg | IV | not captured | standing | page 113 |
| Other | peds | 1–2 mg/kg | IV/IO | not captured | standing | page 192 |
| Other | peds | 1–2 mg/kg | IV | not captured | standing | pages 108, 192 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IM | not captured | standing | pages 65, 72, 77, 192 |
| Other | adult | 100 mg | IV | not captured | standing | page 65 |
| Other | adult | 100 mg | IM | not captured | standing | page 77 |
| Other | adult | 100 mg | IV/IM | not captured | standing | page 192 |
| Other | peds | 25 mg | IV/IM | not captured | standing | pages 65, 72, 77, 192 |
| Other | peds | 25 mg | IV/IM | not captured | standing | page 192 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV | not captured | standing | pages 192, 193 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | pages 67, 89, 192, 193 |
Vancomycin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 7.5 mg/kg | IV | not captured | standing | page 156 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 40 unit | IV | not captured | standing | page 193 |
Ziprasidone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10–20 mg | IM | not captured | standing | pages 144, 180, 181 |
| Other | adult | 10–20 mg | IM | not captured | standing | pages 180, 181 |
Cite this
Adams, Benton, Franklin, Yakima Counties, United States EMS Protocol Census. 274 dose entries, effective 2025-01-01.
https://protoquiz.com/census/agencies/adams-benton-franklin-yakima-counties-ems/
The census is free and not for sale. Only public agencies are named.